LAG3 and depressive symptom measurement: Functionally, it is interesting to note that microglial Lag3 is being studied as a target for the treatment of depression [78] and that α-syn is more highly expressed in patients with major depressive disorder [81], as many patients with synucleinopathies experience depressive symptoms [82,83,84].